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Introduction
olycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disorder affecting women of reproductive age characterized by multiple hormonal imbalances, reflecting on a clinical presentation dominated by manifestations of hyperandrogenism, which generate short and long term consequences on female health (1) . It is a common endocrinopathy affecting 6-10% of reproductive aged women (2) , with a prevalence ranging from 5-10% in the general
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population and almost 30% among obese women (3) . It is multi-factorial, with complex genetic and endocrine disorder; this heterogeneity seems to be modulated by multiple factors, such as prenatal androgen exposure, nutritional status in the uterus, genetic factors, as well as ethnicity, insulin resistance of puberty and/or exaggerated adrenarche and changes in body weight. Environmental factors, such as obesity, appear to exacerbate the underlying genetic predisposition. It is characterized by menstrual disturbances, clinical and biochemical manifestations of hyperandrogenism, ovulatory dysfunction and polycystic ovaries (4) . PCOS is associated with an approximately 7-fold increased risk of type 2 diabetes mellitus (5) . Insulin resistance (IR) and pancreatic β cell dysfunction are major risk factors for the development of type 2 diabetes mellitus. Defects in insulin action and insulin secretion are critical determinants in the pathogenesis of glucose intolerance in PCOS and both are influenced by genetic and environmental factors (6) . PCOS is manifested by abdominal obesity, insulin resistance, dyslipidemia, and endothelial dysfunction. Central adiposity appears to play an important role in the metabolic phenotype through the production of various adipocyte-derived cytokines and proteins known as adipokines (7) . Furthermore, PCOS has been described as a state of chronic low-grade inflammation mainly characterized by a modest rise in serum C-reactive protein compared to the weight matched controls (8) . Because skin is a major target for androgen activity, several hyperandrogenemia-triggered dermatologic alterations can be seen in PCOS, most commonly hirsutism, androgenic alopecia, and acne and also seborrhea, onycholysis, and onychorrhexis (9) . Hirsutism: is defined as the presence of excessive terminal hair in areas of the body that are androgen dependent and usually hairless or with limited hair growth such as the face, chest, areolas, abdomen, and upper thighs (10) . Although hyperandrogenemia is the trigger for hirsutism, the rate of hair growth is not proportional to the degree of hyperandrogenism (11) . Acne and Seborrhea: Sebaceous glands are also androgen-dependent structures, with adipocytes being highly sensitive to androgen signaling, which is exacerbated in PCOS, leading to the development of acne and seborrhea (12) . Androgenic Alopecia: is a disorder in which, hair is miniaturized, due to an increased telogen:anagen ratio "with telogen hair being at mitotical rest and anagen hair being mitotically active" and associated to genetic susceptibility related to increased 5 -reductase activity in the hair follicle. This increased enzymatic activity would favor the local conversion of testosterone into dihydrotestosterone, a more powerful androgen (13) . The diagnosis of PCOS is based on the Rotterdam criteria (14) with women satisfying at least two of the following three criteria: 1) oligomenorrhea/oligoovulation 2) clinical or biochemical hyperandrogenism 3) polycystic ovaries on ultrasound examination. Zinc is one of the most important trace elements required as a catalytic, structural, and regulatory ion for the activities of more than 300 enzymes, proteins, and transcriptional factors (15) . Therefore, zinc is a key element in many homeostatic responses of the body, including oxidative stress and in many biological functions, including immune efficiency (16) . Zinc keeps hormone like estrogen, progesterone and testosterone levels stable throughout the entire menstrual cycle. Zinc is reported to be necessary for DNA replication, RNA polymerases, protein synthesis and various metabolic processes. The cell replication, protein synthesis and growth processes etc. are reported to be to some extent dependent upon zinc (17) . It is known that the adult human body have about 1-3 g of zinc, and about 0.1% of which is replenished daily (18) .
Zinc insufficiency in the female can lead to complications such as impaired synthesis/secretion of follicle stimulating hormone (FSH) and luteinizing hormone (LH), abnormal ovarian development, estrous cycle disruption, frequent abortion, extended gestation period, teratogenicity, stillbirths, complexity in parturition, pre-eclampsia, toxemia and inferior infant birth weights (19) . Oocytes have shown to express most of the zinc transporters, metallothioneins and metal regulatory transcription factor which may point out a significant role for zinc, in particular with potential linkage toward genome stability during early embryonic development (20) . This study aimed to assess serum zinc level in patients with PCOS.
Methods
A case-controlled study was conducted in AlImamein Al-Kadhemein Medical City from the period of March to June 2016. Eighty females were enrolled in this study; their age ranged from 20 to 32 years. Blood samples were obtained from all subjects for serum zinc, serum prolactin (PRL), serum FSH and serum LH assessments. All subjects had pelvic ultrasonography and body mass index (BMI) measurements. Exclusion criteria were: chronic or acute medical illnesses, pregnancy, hypothyroidism, and current or previous (within last 2 months) use of any medications known to affect inflammation, anti-diabetic and anti-obesity drugs, insulin or vitamin and mineral supplements. The subjects were divided into 4 groups: Group I: Twenty patients with PCOS with BMI ranged from 30.0-40.0 Group II: Twenty normal healthy control obese ladies with BMI ranged from 30.0-40.0 Group III: Twenty patients with PCOS with BMI ranged from 18.5-29.9. Group IV: Twenty non-obese ladies as a healthy control with BMI ranged from 18.5-29.9. Table 1 shows no significant differences in age and in BMI between PCO patients and control group. Serum PRL level was significantly higher in PCO group (15.07±8.42) than in the control group (9.19±2.2) with P value = 0.0001. Also, serum LH level was significantly higher in PCO group (6.48±4.36) than in control group (4.57±1.8) with P value = 0.0123. There were no significant differences in serum FSH level and serum Zinc level between PCO patients and control group in this study. figure (1) .
Results
PCO group vs control group
Figure 1. Level of serum zinc in four study groups Farhood, Assessment of Serum Zinc Level in Patients with PCOS
Correlation of serum zinc with other parameters in the four study groups There was significant negative correlation between serum zinc level and serum PRL level in obese PCO patients. While in non-obese PCO patients, there was significant negative correlation between serum zinc level with BMI and serum PRL as shown in table (6). Correlation of serum zinc with other parameters in control and PCO groups There was significant negative correlation between serum zinc level with BMI and serum PRL level in PCO patients, which was not significant in control group as shown in table (7). 
Discussion
Polycystic ovary syndrome is the most common endocrine-metabolic disorder. It can be defined as a combination of hyperandrogenism (hirsutism and acne) and anovulation (oligomenorrhea, infertility, and dysfunctional uterine bleeding) with polycystic ovaries (1) . Serum PRL level was significantly higher in PCO group than in control group with P value < 0.0001, which is consistent with other study (21) . This increased PRL level may augment adrenal androgen secretion by the inhibition of 3-betahydroxysteroid dehydrogenase activity or, less often, through selective action on the sulfation of DHEA in adrenal or extra-adrenal sites. However, PRL inhibits FSH-induced ovarian aromatase, leading to intraovarian hyperandrogenemia (22) . Serum LH level was significantly increased in PCO group than in control group with P value < 0.01, which is consistent with other study (23) . Serum PRL level and serum LH level in obese PCO group were highly significantly increased compared to obese control group with P value < 0.0001 in which, they were consistent with other study (24) . It can be explained due to abnormality of the hypothalamic-pituitary ovarian or adrenal axis has been implicated in PCOS. Disturbance in gonadotrophin releasing hormone (GnRH) results in the relative increase in LH to FSH release, abnormal feedback mechanism by ovarian estrogen is blamed to play role in this discriminated increase in LH release (25) . Serum zinc level was significantly decreased in obese PCO group than in obese control group with P value < 0.02, which is different from other study which showed no significant difference between patients group and control group with respect to serum zinc levels (P > 0.05) (26) .
One of the possible mechanisms of zinc relationship to PCOS other than insulin signaling system defects may be its effect on oxidative stress, zinc is a potent antioxidant and its deficiency causes increased oxidative damage in multiple organs, including the heart (27) .
Oxidative stress induces infertility in women through a variety of mechanisms. Excess reactive oxygen species (ROS) in the follicle may overwhelm follicular fluid antioxidant defense and directly damage oocytes. The DNA of oocytes and spermatozoa may be damaged, leading to defective fertilization when the peritoneal cavity microenvironment is plagued with severe oxidative stress. Even when fertilization is achieved, oxidative stressinduced apoptosis may result in embryo fragmentation, implantation failure, abortion, impaired placentation, and congenital abnormalities (28) . Excess ROS may hinder the endometrium, which normally functions to support the embryo and its development (29) . Oxidative stress may induce luteal regression and insufficient luteal hormonal support for the continuation of a pregnancy (30) . Non-obese PCO patients without insulin resistance also have been reported to have elevated total oxidant and antioxidant status. Verit et al. demonstrated that total antioxidant status in these types of PCO patients was correlated with raised LH levels and free androgen and dehydroepiandrosterone (DHEAS) levels (31) .
There was significant negative correlation between serum zinc level and BMI in PCO patients. It has been found that BMI and PRL are all inversely associated with arsenic, cadmium, copper, lead, manganese, molybdenum, and Zn (32) . Obese individuals have lower blood concentrations of some vitamins and minerals compared to non-obese individuals (33) . Also, it has been observed that zinc concentration is directly associated with serum leptin concentration (34) . So leptin resistance that occurred in obesity might have resulted from zinc deficiency in which, zinc may either directly affect leptin gene expression or indirectly cause leptin production by increasing glucose use of the fatty tissue. Also, there was significant negative correlation between serum zinc level and serum PRL level in non-obese PCO patients. This had been shown in a wide number of in vitro studies in which, an inverse relationship between zinc and PRL. Zinc interferes physiologically and pharmacologically in the synthesis, storage, release and peripheral action of PRL. Interaction with calcium-channels, calciumcalmodulin complex, adenylate cyclase, secretory granules, membrane stabilization and membrane receptors are some of proposed mechanisms of Zinc involvement in PRL secretion, as was reviewed by Brando-Neto et al (35) . It is concluded that serum zinc level reduced in obese PCO than in non-obese PCO. The level of serum zinc is negatively correlated with BMI and serum PRL level.
